| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,480 | $30 | $356.1K |
| J3262 | Injection, tocilizumab, 1 mg | 38,800 | $10 | $194K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 42,400 | $1 | $169.6K |
| J9312 | Injection, rituximab, 10 mg | 2,600 | $60 | $153.4K |
| J0897 | Injection, denosumab, 1 mg | 6,960 | $20 | $125.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 730 | $80 | $60.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,140 | $30 | $55.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $90 | $31.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 350 | $50 | $18.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $110 | $5.9K |